Overcoming challenges in the industrialisation of iPSC-derived therapies

Tune into this webinar to learn how the Cell and Gene Therapy Catapult is working to address some of the key manufacturing challenges within the allogeneic cell therapy field.

Watch the Webinar

Please provide your details to gain access.

The Cell and Gene Therapy Catapult takes your data very seriously. By using this form you are consenting to the processing of your personal data as per ourprivacy policy.

In this webinar, Marcia Mata, Associate Lead Scientist at the Cell and Gene Therapy Catapult (CGT Catapult), will discuss examples of how we are working to address key manufacturing challenges within the allogeneic cell therapy field; developing scalable, automated and controlled processes to help bring these pioneering advanced therapies to patients. Marcia will be joined by Marina Tarunina, Research Director at Plasticell, who will give a talk on a recent collaborative project with CGT Catapult, highlighting how it is supporting the development of their stem cell technologies and helped them to get to where they are now.

This webinar is the first in a series covering our Challenge Themes and the collaborative research projects that are helping us to identify effective solutions to the challenges facing the advanced therapies sector.

Agenda:
12:00-12:05Introductions and housekeeping - Amy Severs, Collaborations Manager, CGT Catapult

12:05-12:20Towards industrialisation of iPSC-derived allogeneic cell therapy - Marcia Mata, Associate Lead Scientist, CGT Catapult

12:20 – 12:35Talk title TBC - Marina Tarunina, Research Director, Plasticell

12:35 – 12:45 – Q&A session